Lineage Cell Therapeutics, Inc. Share Price
Stocks
LCTX
US53566P1093
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.065 USD | +3.40% |
|
-6.14% | -35.93% |
| 07-13 | Lineage Cell Therapeutics, Inc. - Special Call | |
| 07-13 | Lineage Cell Therapeutics Provides Update On COR1 Cell Therapy Program For Corneal Endothelial Disease | CI |
| Market Cap | 257M 226M 210M 193M 362M 24.62B 367M 2.5B 975M 12.16B 964M 943M 42.03B | P/E 2026 * |
-15x | P/E 2027 * | -11.3x |
|---|---|---|---|---|---|
| Enterprise Value | 257M 226M 210M 193M 362M 24.62B 367M 2.5B 975M 12.16B 964M 943M 42.03B | EV / Sales 2026 * |
14.3x | EV / Sales 2027 * | 14.2x |
| Free-Float |
95.07% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Lineage Cell Therapeutics, Inc.
| 1 day | +3.40% | ||
| 1 week | -6.14% | ||
| Current month | -18.32% | ||
| 1 month | -20.74% | ||
| 3 months | -31.41% | ||
| 6 months | -32.28% | ||
| Current year | -35.93% |
| 1 week | 1 |  | 1.14 |
| 1 month | 1 | | 1.38 |
| Current year | 1 | | 1.98 |
| 1 year | 0.95 | | 2.09 |
| 3 years | 0.37 | | 2.09 |
| 5 years | 0.37 | | 2.8 |
| 10 years | 0.37 | | 4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Brian Culley
CEO | Chief Executive Officer | 54 | 16/09/2018 |
Jill Howe
DFI | Director of Finance/CFO | 50 | 13/11/2022 |
| Chief Operating Officer | - | 30/11/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
Neal Bradsher
BRD | Director/Board Member | 60 | 30/06/2009 |
Deborah Andrews
BRD | Director/Board Member | 68 | 10/04/2014 |
Michael Mulroy
CHM | Chairman | 60 | 26/04/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/07/26 | Broadwood Capital, Inc.
| Free | Company | 125,000 | 0.0501% | |
| 01/07/26 | Free | Director | 125,000 | 0.0501% | ||
| 01/07/26 | Free | Director | 125,000 | 0.0501% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.40% | -6.14% | -8.55% | -24.11% | 257M | |
| +0.14% | -0.67% | -0.88% | +11.02% | 47.74B | |
| -1.98% | +0.82% | +395.97% | +618.79% | 39.98B | |
| +0.57% | +2.93% | +11.38% | +45.70% | 36.23B | |
| +12.39% | +19.43% | +21.76% | +6.48% | 35.59B | |
| -0.73% | +2.78% | +4.65% | +41.16% | 27.91B | |
| -1.45% | -2.18% | - | - | 16.71B | |
| -1.67% | +10.27% | +29.41% | +130.09% | 16.45B | |
| +2.39% | -1.64% | +4.74% | +9.95% | 13.21B | |
| +7.35% | +8.46% | -4.72% | -28.33% | 12.93B | |
| Average | +2.10% | +1.38% | +50.42% | +90.08% | 24.7B | |
| Weighted average by Cap. | +1.89% | +2.94% | +76.38% | +131.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 17.94M 15.77M 14.68M 13.48M 25.32M 1.72B 25.65M 175M 68.16M 850M 67.36M 65.9M 2.94B | 18.14M 15.95M 14.85M 13.63M 25.6M 1.74B 25.94M 176M 68.92M 859M 68.11M 66.64M 2.97B |
| Net income | -24.11M -21.19M -19.73M -18.12M -34.02M -2.31B -34.47M -235M -91.59M -1.14B -90.5M -88.55M -3.95B | -31.83M -27.98M -26.04M -23.92M -44.91M -3.05B -45.51M -310M -121M -1.51B -119M -117M -5.21B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/07/26 | US$1.070 | +3.88% | 416,200 |
| 27/07/26 | US$1.030 | 0.00% | 1,709,017 |
| 24/07/26 | US$1.030 | -3.74% | 1,230,874 |
| 23/07/26 | US$1.070 | -3.60% | 1,025,069 |
| 22/07/26 | US$1.110 | -2.63% | 774,308 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LCTX Stock
Select your edition
All financial news and data tailored to specific country editions
